For research use only
| Cat No. | ABC-TC0344 |
| Product Type | Human Uterine Cancer Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Uterus |
| Disease | Endometrial Adenocarinoma |
| Product Code | Hec-1-B; HEC-1B; Hec-1b; HEC1-B; HEC1B; Hec1B |
Endometrial carcinoma
HEC-1-B is a human endometrial carcinoma cell line originally derived from a female patient. The cells exhibit epithelial morphology and grow as monolayers under adherent culture conditions. Karyotype analysis reveals a diploid to tetraploid chromosomal content with the presence of large submetacentric marker chromosomes. HEC-1-B displays invasive and migratory behavior in vitro and is capable of forming tumors in immunodeficient mice. These features make it a powerful and widely accepted model for studying endometrial cancer progression, metastasis, and therapeutic response in preclinical research. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Hec-1-B; HEC-1B; Hec-1b; HEC1-B; HEC1B; Hec1B |
| Species | Human |
| Cat.No | ABC-TC0344 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Uterus |
| Disease | Endometrial Adenocarinoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Uterine Cancer Cell Lines |
HEC-1-B cell line is widely used in endometrial cancer research to study tumor cell invasion, proliferation, hormone response, and drug efficacy in vitro. Its epithelial morphology and metastatic potential in xenograft models make it suitable for assays investigating cell adhesion, migration, and interaction with extracellular matrix components. This cell line is also applicable for testing targeted therapeutics, evaluating hormonal regulation pathways, and modeling resistance mechanisms in reproductive oncology research.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
